Precedent Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$647K Sell
1,788
-6,358
-78% -$2.18M 0.11% 131
2026
Q1
$2.87M Buy
8,146
+206
+3% +$73.4K 0.57% 55
2025
Q4
$2.6M Buy
7,940
+371
+5% +$118K 0.55% 59
2025
Q3
$2.14M Buy
7,569
+433
+6% +$126K 0.47% 66
2025
Q2
$1.99M Buy
7,136
+877
+14% +$248K 0.49% 61
2025
Q1
$1.95M Buy
6,259
+852
+16% +$252K 0.54% 57
2024
Q4
$1.41M Buy
5,407
+176
+3% +$52.2K 0.46% 61
2024
Q3
$1.69M Buy
5,231
+421
+9% +$138K 0.56% 40
2024
Q2
$1.5M Buy
4,810
+248
+5% +$72.9K 0.61% 37
2024
Q1
$1.3M Buy
4,562
+307
+7% +$89.8K 0.56% 40
2023
Q4
$1.23M Buy
+4,255
New +$1.16M 0.62% 34

Other funds holding AMGN

Precedent Wealth Partners's AMGN Position: Q2 2026 in Review

Precedent Wealth Partners reduced its Amgen (AMGN) stake by 78% in Q2 2026, selling an estimated $2.18M and leaving 1,788 shares worth $647K. The position accounts for 0.11% of the portfolio, ranked #131.

Precedent Wealth Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.87M in Q1 2026. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Precedent Wealth Partners held 1,788 shares of Amgen worth $647K as of Q2 2026.
  • Precedent Wealth Partners sold 6,358 Amgen shares in Q2 2026, an estimated $2.18M.
  • Amgen made up 0.11% of Precedent Wealth Partners's portfolio in Q2 2026, its #131 holding.
  • Precedent Wealth Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Precedent Wealth Partners's Amgen position peaked at $2.87M in Q1 2026.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Precedent Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.